Natixis Advisors, L.P.

SEC CIK: 0001018331
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Natixis Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overview All 13F holders of VRTX Full Q2 2026 holdings

Shares (Q2 2026): 448,631
Value: $222.8M
% of portfolio: 0.3%
Quarters held: 22; Since Q1 2021

Holdings of VRTX by Natixis Advisors, L.P., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	448,631	$222.8M	0.3%	−105,393−19.0%	Reduced	Holders
Q1 2026	554,024	$247.4M	0.3%	+26,160+5.0%	Added	Holders
Q4 2025	527,864	$239.3M	0.3%	−9,330−1.7%	Reduced	Holders
Q3 2025	537,194	$210.4M	0.3%	−3,336−0.6%	Reduced	Holders
Q2 2025	540,530	$240.6M	0.4%	−60,657−10.1%	Reduced	Holders
Q1 2025	601,187	$291.5M	0.5%	+43,543+7.8%	Added	Holders
Q4 2024	557,644	$224.6M	0.4%	+95,758+20.7%	Added	Holders
Q3 2024	461,886	$214.8M	0.4%	+25,301+5.8%	Added	Holders
Q2 2024	436,585	$204.6M	0.4%	+104,522+31.5%	Added	Holders
Q1 2024	332,063	$138.8M	0.3%	+12,587+3.9%	Added	Holders
Q4 2023	319,476	$130.0M	0.3%	+266+0.1%	Added	Holders
Q3 2023	319,210	$111.0M	0.3%	−153,998−32.5%	Reduced	Holders
Q2 2023	473,208	$166.5M	0.5%	+10,220+2.2%	Added	Holders
Q1 2023	462,988	$145.9M	0.5%	−4,344−0.9%	Reduced	Holders
Q4 2022	467,332	$135.0M	0.5%	−41,088−8.1%	Reduced	Holders
Q3 2022	508,420	$147.2M	0.6%	−95,775−15.9%	Reduced	Holders
Q2 2022	604,195	$170.3M	0.7%	−66,323−9.9%	Reduced	Holders
Q1 2022	670,518	$175.0M	0.7%	+2,716+0.4%	Added	Holders
Q4 2021	667,802	$146.7M	0.6%	+51,094+8.3%	Added	Holders
Q3 2021	616,708	$111.9M	0.5%	+407,937+195.4%	Added	Holders
Q2 2021	208,771	$42.1M	0.2%	+37,665+22.0%	Added	Holders
Q1 2021	171,106	$36.8M	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.